Healthcare Resource Utilization and Costs Among Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients: A Retrospective Cohort Study Using Contemporary US Claims

被引：0
|
作者：
Huntington, Scott F. [1 ]
Chang, Hsien-Yen [2 ]
Fu, Alex Z. [2 ,3 ]
Loefgren, Christina [4 ]
Lu, Xiaoxiao [5 ]
机构：
[1] Yale Univ, Div Hematol, New Haven, CT USA
[2] Janssen Sci Affairs LLC, Titusville, NJ USA
[3] Georgetown Univ, Med Ctr, Washington, DC USA
[4] Janssen Global Serv LLC, Raritan, NJ USA
[5] Janssen Sci Affairs LLC, Real World Value & Evidence, Horsham, PA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-181909
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Examining Healthcare Resource Utilization (HCRU) and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia (AML)
    Tabah, Ashley
    Knoth, Russell
    Huggar, David
    Copher, Ronda M.
    Cao, Zhun
    Lipkin, Craig
    Leblanc, Thomas W.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S181 - S181
  • [2] ANNUAL HEALTHCARE RESOURCE UTILIZATION AND COSTS IN US PATIENTS DIAGNOSED WITH RELAPSED ACUTE MYELOID LEUKEMIA
    Huggar, D.
    Knoth, R. L.
    Cao, Z.
    Lipkin, C.
    Copher, R.
    LeBlanc, T. W.
    VALUE IN HEALTH, 2021, 24 : S28 - S28
  • [3] Annual Healthcare Resource Utilization and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia
    Tabah, Ashley
    Knoth, Russell L.
    Huggar, David
    Copher, Ronda
    Cao, Zhun
    Lipkin, Craig
    Leblanc, Thomas W.
    BLOOD, 2020, 136
  • [4] Healthcare resource utilization and costs in patients with newly diagnosed acute myeloid leukemia
    Hagiwara, May
    Sharma, Arati
    Chung, Karen C.
    Delea, Thomas E.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (11) : 1119 - 1130
  • [5] Real-World Treatment Patterns and Overall Survival Among Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients: A Retrospective Cohort Study Using Claims Data
    Huntington, Scott F.
    Chang, Hsien-Yen
    Fu, Alex Z.
    Loefgren, Christina
    Lu, Xiaoxiao
    BLOOD, 2023, 142
  • [6] Healthcare Resource Utilization and Costs in US Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Chemotherapy
    Huggar, David
    Knoth, Russell L.
    Copher, Ronda
    Cao, Zhun
    Lipkin, Craig
    McBride, Ali
    LeBlanc, Thomas W.
    BLOOD, 2021, 138
  • [7] Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
    Stein, Eytan M.
    Latremouille-Viau, Dominick
    Guerin, Annie
    Shi, Sherry
    Gagnon-Sanschagrin, Patrick
    Bonifacio, Gaetano
    Joseph, George J.
    BLOOD, 2016, 128 (22)
  • [8] Acute Myeloid Leukemia (AML): A Retrospective Claims Analysis of Resource Utilization and Expenditures
    Irish, William D.
    Ryan, Michael
    Gache, Larry
    Gunnarsson, Candace
    Bell, Timothy
    Shapiro, Mark
    BLOOD, 2015, 126 (23)
  • [9] HEALTHCARE RESOURCE UTILIZATION (HCRU) AND ASSOCIATED COSTS AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH ORAL AZACITIDINE AS MAINTENANCE AND THOSE ELIGIBLE BUT NOT TREATED USING A US CLAIMS DATABASE
    Borate, U.
    Seiter, K.
    Potluri, R.
    Mazumder, D.
    Heydendael, W.
    Chevli, M.
    Prebet, T.
    Strocchia, M.
    Vasconcelos, A.
    Sieluk, J.
    VALUE IN HEALTH, 2023, 26 (12) : S67 - S67
  • [10] Healthcare Resource Utilization (HCRU) in Patients (pts) with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Treated in the Connect® MDS/AML Disease Registry
    Mukherjee, Sudipto
    Abedi, Mehrdad
    Erba, Harry P.
    Pollyea, Daniel A.
    Roboz, Gail J.
    Thompson, Michael A.
    Louis, Chrystal U.
    Flick, E. Dawn
    Nifenecker, Melissa
    Kiselev, Pavel
    Swern, Arlene S.
    Cogle, Christopher R.
    BLOOD, 2018, 132
12345